‎‎NAF RECEIVES FIVE NEW HELICOPTERS AS FG ACCELERATES AIRPOWER MODERNISATION. (PHOTO).

Image
 ‎‎NAF RECEIVES FIVE NEW HELICOPTERS AS FG ACCELERATES AIRPOWER MODERNISATION ‎ The Nigerian Air Force (NAF) has taken delivery of five new helicopters as the Federal Government accelerates efforts to modernize Nigeria’s airpower capabilities and strengthen the Armed Forces’ capacity to respond effectively to contemporary security challenges.  ‎ ‎A statement by the Director of Public Relations and Information Air Commodore Ehimen Ejodame indicates that the platforms comprise three AW-109 Trekker B helicopters  and two H-125 helicopters. ‎ The three AW-109s, which form part of 10 recently acquired by the Federal Government, were received in Lagos on 15 September 2026, with the remaining seven expected to be delivered before the end of 2026. ‎ ‎The Chief of the Air Staff, Air Marshal Sunday Aneke, described the acquisition as another significant milestone in the Federal Government’s sustained investment in the modernization and re-equipment of the NAF noting that the new pl...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.